secwatch.observer — SEC 8-K summary
======================================

Issuer:     LeonaBio, Inc. (LONA)
CIK:        0001620463
Form:       8-K
Filed at:   2026-03-19T23:59:59+00:00
Accession:  0001193125-26-116123
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LeonaBio shareholders approve 2026 equity plan, 4x authorized share increase, and Sermonix warrant exercise
--------------------------------------------------------------------------------

- Authorized common shares increased from 90M to 400M; total capital stock from 190M to 500M.
- 2026 Equity Incentive Plan approved: up to 5.7M shares initially, plus potential additions from lapsed 2020 Plan awards.
- Stockholders approved issuance of 5,502,402 shares upon exercise of Sermonix pre-funded warrant.
- Issuance to Sermonix and Perceptive Advisors exceeding 19.99% beneficial ownership also approved.
- 2026 Plan includes annual evergreen increase equal to the lesser of 5% of outstanding shares or Board-determined amount.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1620463/000119312526116123/0001193125-26-116123-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1620463/000119312526116123/lona-20260318.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-116123

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer